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In mammals, helper T cells orchestrate defense against diverse pathogens. However, 
these warriors of the immune system can also result in self-inflicted injury culminating in 
autoimmune and allergic diseases. Recent findings—such as the discovery of the Th17 
lineage—have revealed additional complexity in the fates chosen by helper T cells and 
have begun to reshape our view of how signaling and transcriptional networks generate 
appropriate and inappropriate immunity.About two decades ago, a hypothesis was formulated to 
explain how the varied nature of the mammalian immune 
response could be linked to the outcome of helper T cell 
maturation (Mosmann et al., 1986). The initial insights 
for such diversity came from seminal studies examin-
ing antigen-specific helper T cell clones from immu-
nized mice. Based on functional bioassays and protein 
expression studies, these clones were categorized as 
Th1 and Th2 cells, which appeared to provide qualita-
tively different forms of help to B cells and other arms 
of the immune repertoire by secreting unique subsets of 
cytokines. Since then, it has been presumed that phago-
cytic and intracellular defense is orchestrated by Th1 
cells, whereas nonphagocytic and extracellular defense 
is orchestrated by Th2 cells. The price paid for the ben-
efit of adaptive immunity, however, is disease mediated 
by lymphocytes, including autoimmunity and allergy. In 
general, it has been thought that Th1 cells are the cul-
prits in organ-specific autoimmunity whereas Th2 cells 
mediate allergy and asthma.
Recently, a variety of findings have suggested that 
the spectrum of the immune repertoire could not be 
completely explained by a simple binary fate choice by 
a helper T cell (reviewed in Dong, 2006; Weaver et al., 
2006). This undercurrent of additional complexity in the 
Th1-Th2 hypothesis has now culminated in the discovery 
of a new helper T cell subset (Th17 cells), the characteri-
zation of its roles in host defense and autoimmunity, and 
discovery of a transcription factor, RORγt, that appears to 
specify its cellular identity (Ivanov et al., 2006). Together, 
these new findings about how helper T cells function and 
malfunction have contributed to an emerging portrait of 
the immune response as a cellular system that exploits 
key principles of developmentally regulated signaling 
and transcriptional networks to achieve remarkable 
plasticity in cell specification. As a consequence of this 
new information, misfiring in the complex circuitry that 
leads to immune-mediated disease may now be more 
amenable to therapeutic intervention.Mammalian Immune Responses Mobilize Diverse 
Defense Mechanisms
Adaptive immunity is a cellular network, unique to 
advanced vertebrate species, which has grown in 
complexity during evolution, perhaps proportion-
ate to the complexity of microbial enemies that con-
front terrestrial beings. The cornerstones of adaptive 
immunity are lymphocytes. B lymphocytes provide 
defense via the secretion of antibodies. CD8+ (cyto-
toxic) T cells mediate defense by virtue of their direct 
killing of infected target cells. In contrast to the other 
lymphocytes, CD4+ (helper) T cells orchestrate and 
mobilize a variety of other cell types to do their bid-
ding. Helper T cells activate and/or recruit other lym-
phocytes, evolutionarily older (innate) immune cells, 
and even nonimmune cells, such as epithelia, to 
achieve clearance of the offending pathogen.
A central theme of adaptive immunity is diversity. Each 
lymphocyte expresses a different antigen receptor to 
allow a response against virtually any potential microbial 
invader. To initiate helper T cell differentiation, a migrant 
dendritic cell enters the lymph node with evidence it has 
encountered a pathogen in an infected tissue (Figure 
1). The rare, patrolling, pathogen-specific T cell, upon 
encountering the sentinel dendritic cell, must then divide 
numerous times to achieve a critical mass that is suit-
able to the defense against the microbial opponent. 
Because pathogens exhibit diverse lifestyles and eva-
sion strategies, the dendritic cell also instructs the T cell, 
through both well and poorly understood mechanisms, 
in the nature and location of the threat. Is it intracellu-
lar or extracellular? Is it viral, bacterial, or eukaryotic? In 
which tissue is it currently residing? A selected helper 
T cell must, therefore, match the inducible changes in 
gene expression of its progeny to fit the life cycle of the 
microbe it is seeking to eliminate. The predominance of 
helper T cell fate, by virtue of the unique cytokines that 
are secreted, will determine which other immune and 
nonimmune cells will be mobilized to battle.Cell 129, April 6, 2007 ©2007 Elsevier Inc. 33
Figure 1. Heterogeneity in Helper T Cell 
Fates
The helper T cell differentiation process is 
initiated by signaling from dendritic cell to T 
cell in the lymph node, resulting in division 
and differentiation. The mature helper T cells 
and their signature transcription factors are 
illustrated. Cytokines (listed above) play a 
critical role in the induction or repression of 
the lineages. The different helper T cell sub-
sets have distinct protective and pathological 
roles (listed below). Host defense is orches-
trated by the three major fates, Th1, Th2, and 
Th17. Adaptive regulatory T (aTreg) cells can 
downregulate immune responses, although a 
physiological role in vivo is yet uncertain. The 
mature helper T cell progeny must eventually 
exit the lymph node and migrate to infected 
tissue to exert their function in host defense. 
Some of the mature progeny may, instead, 
migrate to B cell follicles to promote antibody 
subclasses that will suit the particular im-
mune response.Signaling through the Cell Generations
The signaling by the dendritic cell, which is primarily 
bestowed on the initial naïve helper T cell (and its first 
few daughter cells), must somehow be relayed to sub-
sequent cell generations, who are the actual executors 
of the original instructions. These later cellular progeny 
of the selected T cell must leave the inductive sanctu-
ary that is the secondary lymphoid organ and migrate to 
sites of infection and inflammation with a lasting imprint 
of the inductive signal in order to orchestrate the appro-
priate defense mechanisms. It may, therefore, not be sur-
prising that epigenetic effects have emerged as a criti-
cal principle of gene regulation in the incipient immune 
response (Ansel et al., 2003; Murphy and Reiner, 2002). 
Heritable alterations in chromatin modifications and pat-
terns of DNA methylation together with self-reinforcing 
transcription factor networks provide a mechanism for 
inductive signals to be remembered through the space 
and time of cell division and tissue migration.
The Importance of Cytokines
Dendritic cells recognize differences between various 
classes of pathogens via microbial pattern-recognition 
receptors and then parlay this information into unique 
signals to the microbe-specific T cell. Among the most 
critical signals that direct the induced patterns of gene 
expression in maturing helper T cells are cytokines (Dong, 
2006; Murphy and Reiner, 2002; Weaver et al., 2006). The 
actions of cytokines that stimulate helper T cell matura-
tion can range from the induction or repression of criti-
cal lineage-specifying transcription factors to that of a 
selective growth factor for a specific lineage (Figure 1). 
Cytokines are also the critical messengers secreted by 
mature helper T cells to mediate their influence on other 
cells during the immune response. IFN-γ is the signature 
cytokine expressed by Th1 cells, whereas IL-4 secretion 
is a signature of Th2 cells. IL-17 is a signature of the lat-
est subset to be described, earning it the name Th17. The 34 Cell 129, April 6, 2007 ©2007 Elsevier Inc.cytokines produced by a given helper T cell subset often 
serve as potent inducers of the differentiation of that sub-
set as well as negative regulators of the other subsets.
The Th1-Th2 Paradigm Evolves
One of the most critical cytokines produced by den-
dritic cells for the induction of Th1 responses is IL-12. 
This heterodimeric cytokine is typically secreted by 
activated dendritic cells that have been exposed to bac-
teria ligands, such as unmethylated CpG and lipopoly-
saccharide. IL-12 is also secreted by dendritic cells and 
macrophages in response to parasitization by intra-
cellular prokaryotes, eukaryotes, and some viruses. 
IL-12 is a key inducer and growth factor of polarized 
Th1 responses insofar as it represses expression of 
the transcription factor Gata-3, a key regulator of Th2 
commitment. IL-12 also promotes survival, growth, and 
gene expression of Th1 cells. The IL-12 heterodimer 
is composed of a p40 and p35 subunit. Experiments 
antagonizing IL-12 using neutralizing antibodies against 
p40 or exploiting p40-deficient mice helped to elabo-
rate the important role of IL-12-directed Th1 responses 
in immunity and autoimmunity.
More than a decade after the initial discovery of IL-
12, however, it became apparent that another IL-12 
family member, IL-23, shares use of the p40 subunit of 
IL-12. IL-23 is a heterodimer composed of the nonpro-
prietary p40 subunit and its private subunit, p19. There 
is a parallel of shared utilization by the receptors for 
these cytokines. IL-12 and IL-23 receptors both use 
the receptor IL-12Rβ1. For IL-12, the second subunit is 
IL-12Rβ2, but for IL-23, the second subunit is IL-23R. 
Subsequent deconstruction of the pathogenesis of 
autoimmune disorders, now paying particular atten-
tion to the distinction between dual loss of function of 
IL-12/IL-23 p40 versus single antagonism or deletion 
of each cytokine alone, led to a startling conclusion: 
IL-12-driven Th1 cells may not be the major culprits in 
organ-specific autoimmunity, but rather a pathogenic, 
IL-23-driven subset may be to blame (Cua et al., 2003; 
Langrish et al., 2005; Murphy et al., 2003; Nakae et 
al., 2003). It was originally thought that the signature 
cytokines expressed by IL-23-driven T cells were exclu-
sively members of the IL-17 family of cytokines, result-
ing in the term Th17 cells, but it is now recognized that 
they also secrete IL-22 (Zheng et al., 2007).
In the short time since the discovery of IL-23, this IL-12-
related cytokine and/or the Th17 subset has been impli-
cated in numerous autoimmune and inflammatory con-
ditions including arthritis, multiple sclerosis, psoriasis, 
and inflammatory bowel disease (Cua et al., 2003; Duerr 
et al., 2006; Langrish et al., 2005; Murphy et al., 2003; 
Nakae et al., 2003; Zheng et al., 2007). Most immune 
mechanisms, however, are likely to serve some protec-
tive function and not simply cause damage. The unique 
contributions to the immune armamentarium provided 
by Th17 cells appear to be mobilizing acute inflamma-
tion/neutrophilic responses and promoting integrity of 
epithelial surfaces (Dong, 2006; Weaver et al., 2006). IL-
17 elicits secretion of attractant chemokines and matrix 
proteins to yield neutrophil recruitment. In addition, IL-
17 and IL-22 have been implicated in barrier function by 
inducing growth, differentiation, and junctional integrity 
of epithelia. Thus far, the IL-23-related immune response 
has been attributed with providing protection against 
Klebsiella and Citrobacter bacterial species, tentatively 
placing the Th17 subset as the defender against extra-
cellular prokaryotes. In retrospect, Th17 cells seem to fill 
in a gap in the previous repertoire of host defense mech-
anisms by targeting extracellular pathogens at epithe-
lial surfaces (and perhaps systemically), which primarily 
require barrier function and/or neutrophil responses.
Lineage Relationships, Inductive Signals, and 
More Surprises
In the aftermath of the Th17 discovery came a series of 
elegant studies that have suggested that Th17 cells may 
not be simple variants of Th1 cells but, rather, a distinct 
lineage (Harrington et al., 2005; Park et al., 2005). It also 
quickly became apparent that IL-23, although impor-
tant in maintaining Th17 responses, might not be the 
critical inducing cytokine of the Th17 lineage. Instead, 
it appears that the combination of IL-6 and TGF-β acts 
in concert to induce Th17 differentiation (Bettelli et al., 
2006; Mangan et al., 2006; Veldhoen et al., 2006; Fig-
ure 1). Ironically, the Th17-inducing environment sug-
gests a potential kinship between these inflammatory 
mediators and another subset of helper T cells, called 
adaptive regulatory T (aTreg) cells, that serve a distinctly 
anti-inflammatory role. TGF-β, a relatively ubiquitous 
cytokine, suppresses Th1 (and Th2) differentiation while 
inducing aTreg formation. IL-6, a prototypical inflamma-
tory cytokine like TNFα and IL-1, thus acts as a switch in 
the face of TGF-β, directing Th17 cell development by 
its presence or permitting aTreg cells to develop in its 
absence (Figure 1).Master Regulatory Transcription Factors of the 
Helper T Cell Lineages
After the discovery of cytokine regulation of helper T cell 
induction, it became apparent that key transcription fac-
tors uniquely specify the attributes of each mature helper 
T cell lineage (Ansel et al., 2003; Murphy et al., 2003; Fig-
ure 1). Critical cytokines repress or induce the transcrip-
tion of the genes encoding these factors. The transcrip-
tion factors, in turn, define the growth factor preference 
of the cell by activating private cytokine receptor genes. 
In addition, the transcription factors function to estab-
lish remodeled states of chromatin structure of lineage-
specific genes. In essence, the induced expression of 
these factors, their subsequent stabilization through 
autocatalytic and feed-forward mechanisms of signal-
ing and transcriptional networks, and their connection 
to epigenetic remodeling place them as central pieces 
in the puzzle of how immune response signaling can be 
imprinted into a heritable cellular identity over the course 
of division, migration, and time.
Th17 cells do not express the master factors of Th1 
and Th2 cells, T-bet and Gata-3, respectively (Harrington 
et al., 2005; Park et al., 2005; Veldhoen et al., 2006). In 
addition, expression of the Th1 factor, T-bet, seems to 
negatively regulate Th17 differentiation. What, then, is 
the master regulator of Th17 cells? Littman, Cua, and 
their colleagues suggest that the answer is the orphan 
nuclear receptor RORγt (Ivanov et al., 2006). Although 
this transcription factor was not previously implicated in 
mature T cell function, gene arrays pointed to its unique 
expression during Th17 but not Th1 differentiation. Using 
reporter and knockout mice, it was demonstrated that 
Th17 cells exist constitutively in the intestinal lamina pro-
pria and that their development is severely impaired in 
the absence of RORγt. It was found that RORγt expres-
sion is activated by the Th17-inducing cytokine com-
bination of IL-6 plus TGF-β. RORγt also proved to be 
necessary and sufficient for specifying efficient Th17 
induction. Moreover, the loss of RORγt from T cells pre-
vented experimental multiple sclerosis in mice.
These new findings are, thus, harmonious with mounting 
evidence that Th17 cells represent a distinct developmen-
tal lineage. They also support the notion that this subset 
serves a unique role in the immune repertoire, formerly 
thought to be the business of Th1 and Th2 cells (Figure 
1). They likely act at barrier surfaces to provide integrity 
and, failing that, local or systemic inflammation to defend 
us from pathogenic and nonpathogenic extracellular bac-
teria. In addition, they may well be a major culprit in the T 
cell-mediated component of numerous autoimmune and 
inflammatory conditions and could even be implicated in 
the inflammatory links to cancer (Langowski et al., 2006). 
From a therapeutic perspective, it did not escape the atten-
tion of the authors of the RORγt study that the ligand-bind-
ing capacity of a nuclear receptor may render it an easier 
drug target than its counterpart factors, T-bet and Gata-3 
(Ivanov et al., 2006). In the coming months, it is anticipated 
that many remaining issues about the role of RORγt in Th17 Cell 129, April 6, 2007 ©2007 Elsevier Inc. 35
development and function will be addressed. Does RORγt 
induce the IL-23R in a similar fashion to T-bet inducing IL-
12Rβ2? Does RORγt transactivate or induce chromatin 
remodeling of the genes encoding IL-17 and IL-22? What 
effect will conditional deletion or antagonism of RORγt 
have on established immune responses? What will be the 
precise contribution of RORγt-independent pathways to 
autoimmunity and antibacterial host defense?
The Future of Development in Motion
The formerly binary choice between Th1 and Th2 cells 
has now been complicated by the additional choice of 
the Th17 fate, and further complexity has already been 
envisioned (Weaver et al., 2006; Zheng et al., 2007). The 
signaling variables that are integrated at the initiation of 
the immune response would almost appear to be sensory 
overload for an environmentally reactive helper T cell, 
making it difficult to decide among three or more mutu-
ally exclusive fates (Figure 1). Given the inherent delay in 
fate adoption until after the initial cell divisions (Bird et al., 
1998), it is possible that a selected helper T cell, instead 
of making an exclusive choice, might give rise to diverse 
progeny with tendencies toward differing fates. If a single 
T cell could apportion an array of lineage-committed pre-
cursors, using an ancestral mechanism like asymmetric 
cell division (Chang et al., 2007), the eventual predomi-
nance in fate could be shaped by selective growth and 
maturation signals specifically tailored to the pathogen. 
A challenge for the future will be to chronicle the fate of 
the clonal descendants of a lymphocyte called to battle, 
in situ. Unveiling the cellular and subcellular details in the 
initial divisions of a helper T cell in the immune response 
may provide insight into the unique problems facing 
developmental signaling networks in cells that are at once 
dividing, differentiating, and rapidly migrating.
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